Literature DB >> 22997282

Biomarker failures.

John P A Ioannidis1.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22997282     DOI： 10.1373/clinchem.2012.185801

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  30 in total

1.  The diagnostic performance of the Mass Restricted (MR) score in the identification of microbial invasion of the amniotic cavity or intra-amniotic inflammation is not superior to amniotic fluid interleukin-6.

Authors:  Roberto Romero; Nicholas Kadar; Jezid Miranda; Steven J Korzeniewski; Alyse G Schwartz; Piya Chaemsaithong; Wade Rogers; Eleazar Soto; Francesca Gotsch; Lami Yeo; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2013-12-16

2.  High-Throughput Processing to Preserve Viable Cells: A Precision Medicine Initiative Cohort Program Workshop.

Authors:  Rebekah S Rasooly; Daniel R Gossett; Marianne K Henderson; Allison Hubel; Stephen N Thibodeau
Journal:  Biopreserv Biobank       Date:  2017-04-25       Impact factor: 2.300

3.  Generalizable Biomarkers in Critical Care: Toward Precision Medicine.

Authors:  Timothy E Sweeney; Purvesh Khatri
Journal:  Crit Care Med       Date:  2017-06       Impact factor: 7.598

4.  Immunosignature system for diagnosis of cancer.

Authors:  Phillip Stafford; Zbigniew Cichacz; Neal W Woodbury; Stephen Albert Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

5.  Integrative oncology: really the best of both worlds?

Authors:  David H Gorski
Journal:  Nat Rev Cancer       Date:  2014-10       Impact factor: 60.716

Review 6.  From evidence to best practice in laboratory medicine.

Authors:  A Rita Horvath
Journal:  Clin Biochem Rev       Date:  2013-08

Review 7.  Genomic architecture of pharmacological efficacy and adverse events.

Authors:  Aparna Chhibber; Deanna L Kroetz; Kelan G Tantisira; Michael McGeachie; Cheng Cheng; Robert Plenge; Eli Stahl; Wolfgang Sadee; Marylyn D Ritchie; Sarah A Pendergrass
Journal:  Pharmacogenomics       Date:  2014-12       Impact factor: 2.533

Review 8.  Proteomics of ovarian cancer: functional insights and clinical applications.

Authors:  Mohamed A Elzek; Karin D Rodland
Journal:  Cancer Metastasis Rev       Date:  2015-03       Impact factor: 9.264

9.  Human blood gene signature as a marker for smoking exposure: computational approaches of the top ranked teams in the sbv IMPROVER Systems Toxicology challenge.

Authors:  Adi L Tarca; Xiaofeng Gong; Roberto Romero; Wenxin Yang; Zhongqu Duan; Hao Yang; Chengfang Zhang; Peixuan Wang
Journal:  Comput Toxicol       Date:  2017-07-18

10.  Integrated multiomic predictors for ovarian cancer survival.

Authors:  Alan Fu; Helena R Chang; Zuo-Feng Zhang
Journal:  Carcinogenesis       Date:  2018-07-03       Impact factor: 4.944
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.